Gastric and duodenal endoscopic submucosal dissection in patients on aspirin therapy has increased risk of hemorrhage but is feasible

Gastroenterological Endoscopy

Volumn 53, Issue 10, 2011, Pages 3326-3335

  Tounou, Shigetaka ^a   Morita, Yasushi ^a  

^a NEW TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CILOSTAMIDE; CLOPIDOGREL; DIPYRIDAMOLE; RECOMBINANT VON WILLEBRAND FACTOR; TICLOPIDINE;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; DRUG SAFETY; DUODENUM; DUODENUM ULCER; EARLY CANCER; ENDOSCOPIC SUBMUCOSAL DISSECTION; FEMALE; HUMAN; JAPANESE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; STOMACH; STOMACH CANCER; SURGICAL RISK;

EID: 82155186825     PISSN: 03871207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gastroenterol Endosc 2005; 47 : 2691-5.
2. http://www.j-circ.or.jp/guideline/index.htm (web).
3. http://www.j-circ.or.jp/guideline/index.htm (web).
4. Elsen GM, Baron TH, Dominitz JA et al. Standards of Practice Committee. American Society for Gastrointestinal Endoscopy. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedure. Gastrointest Endosc 2002; 55 : 775-98.
5. Veitch AM, Baglin TP, Gershlick AH et al. A working party for the British Society of Gastroenterology, the British committee for Standards in Haematology and the British Cardiovascular Intervention Society. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 2008; 57 : 1322-9.
6. Grines CL, Bonow RO, Casey DE et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents : a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 115 : 813-8. (Pubitemid 46294748)
7. Tamai Y, Komatsu-Ishizawa T, Takami H et al. The management of antiplatelet therapy for endoscopic procedures : The optimal cessation period of antiplatelet therapy for Japanese. Digestive endoscopy 2007; 19 : 161-6. (Pubitemid 47390178)
8. Kimura T, Morimoto T, Nakagawa Y et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009; 119 : 987-95.
9. Gastroenterol Endosc 2009; 51 : 2199.
10. Gotoh F, Tohgi H, Hirai S et al. Cilostazol stroke prevention study : a placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis 2000; 9 : 147-57. (Pubitemid 30480490)
11. Lee SW, Park SW, Yun SC et al. Triple anti-platelet therapy reduces ischemic events after drug -eluting stent implantation : Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry). Am Heart J 2010; 159 : 284-91.
12. Tamai Y, Takami H, Nakahata R et al. Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemostasis using a quantitative bleeding time test apparatus. Haemostasis 1999; 29 : 269-76. (Pubitemid 30207456)
13. Kim JS, Lee KS, Kim YI et al. A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls : analysis with quantitative bleeding time and platelet aggregation test. J Clin Neurosci 2004; 11 : 600-2.
14. Gastroenterol Endosc 2010; 52 : 2976-84.